---
title: "FOXO TECHNOLOGIES INC. (FOXO) news: reverse split"
url: "https://aibio.space/companies/foxo-technologies/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "FOXO reverse split, convertible notes, merger and settlement news: FOXO CEO gives mid-year 2026 update and says uplisting is under consideration."
---

FOXO FOXO TECHNOLOGIES INC. OTC · United States

# FOXO TECHNOLOGIES INC. (FOXO) news FOXO reverse split, convertible notes and merger news

Debt Financing · 2026-10-29

## [FOXO to buy Ludwig Enterprises preferred stock with majority voting power](https://aibio.space/news/foxo-buy-ludwig-enterprises-preferred-stock-majority-voting-power/)

FOXO Technologies signed agreements to acquire preferred stock carrying majority voting power in Ludwig Enterprises, Inc. and to buy certain Ludwig notes. The transactions have not closed.

## Latest FOXO TECHNOLOGIES INC. news

1. 2026-07-29 Company Updates [Vector BioSource agrees to buy four blood collection centers](https://aibio.space/news/vector-biosource-agrees-buy-four-blood-collection-centers/) FOXO subsidiary Vector BioSource, Inc. signed a definitive agreement to acquire four U.S. blood collection centers from Grifols Bio Supplies, Inc. The company expects the deal to close in the third or fourth quarter of 2026.
2. 2026-07-06 Listings [FOXO CEO gives mid-year 2026 update and says uplisting is under consideration](https://aibio.space/news/foxo-ceo-gives-mid-year-2026-update-says-uplisting-under-consideration/) In a letter to shareholders, CEO Seamus Lagan reported first quarter 2026 net revenues of about $5.1 million, completed a 1:3,000 reverse stock split, and said FOXO is considering an uplisting to a recognized exchange before the end of 2026.
3. 2026-07-01 Listings [FOXO completes 1-for-3,000 reverse stock split](https://aibio.space/news/foxo-completes-1-3-000-reverse-stock-split/) The reverse split of FOXO's Class A common stock took effect at 4:01 p.m. ET on June 30, 2026. Shares trade on a split-adjusted basis under the temporary symbol FOXOD until the symbol reverts to FOXO on or about July 20, 2026.
4. 2026-05-28 Company Updates [FOXO licenses its epigenetics technology to LongevityFP](https://aibio.space/news/foxo-licenses-epigenetics-technology-longevityfp/) FOXO Technologies and LongevityFP Technologies, LLC signed an exclusive license on May 28, 2026. LongevityFP will pay a royalty of three percent of its net revenues, capped at $1.3 million.
5. 2026-05-22 Financings [FOXO settles J.H. Darbie fees and seeks a reverse stock split](https://aibio.space/news/foxo-settles-j-h-darbie-fees-seeks-reverse-stock-split/) FOXO settled amounts owed to J.H. Darbie & Co., Inc. with preferred stock and $175,000 in installments. Its majority holder approved a reverse split at a ratio of 1:1,000 to 1:10,000.
6. 2026-05-12 Debt Financing [FOXO exchanges Series A preferred for senior unsecured notes](https://aibio.space/news/foxo-exchanges-series-preferred-senior-unsecured-notes/) Two institutional holders swapped Series A preferred stock for non-convertible notes of $5,307,096.94 and $2,467,988.34, due May 12, 2027.

## FOXO TECHNOLOGIES INC. at a glance

- **Ticker**: FOXO

- **Listing**: OTC

- **Country**: United States

- **Cash, Jun 30, 2026**: $58,409

### Related companies

- [Embecta](https://aibio.space/companies/embecta/) NASDAQ: EMBC
- [HARVARD BIOSCIENCE INC](https://aibio.space/companies/harvard-bioscience/) NASDAQ: HBIO
- [EBR Systems](https://aibio.space/companies/ebr-systems/) OTC: EBRCZ
- [CYANOTECH CORP](https://aibio.space/companies/cyanotech/) OTC: CYAN
- [10x Genomics](https://aibio.space/companies/10x-genomics/) NASDAQ: TXG
- [NATURAL ALTERNATIVES INTERNATIONAL INC](https://aibio.space/companies/natural-alternatives-international/) NASDAQ: NAII
- [Baird Medical Investment Holdings](https://aibio.space/companies/baird-medical-investment/) NASDAQ: BDMD
- [Anteris Technologies Global](https://aibio.space/companies/anteris-technologies-global/) NASDAQ: AVR

### Also on OTC

- [Hongchang International Co.](https://aibio.space/companies/hongchang-international/) HCIL
- [Scorpius Holdings](https://aibio.space/companies/scorpius/) SCPX
- [CYANOTECH CORP](https://aibio.space/companies/cyanotech/) CYAN
- [SKYTECH ORION GLOBAL CORP.](https://aibio.space/companies/skytech-orion-global/) SKTG
- [Beroni Group](https://aibio.space/companies/beroni/) BNIGF
- [PONIARD PHARMACEUT](https://aibio.space/companies/poniard-pharmaceut/) PARD

## FOXO TECHNOLOGIES INC. annual financials

| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | [$16.4 million](https://www.sec.gov/Archives/edgar/data/1812360/000149315226016725/) | [$4.1 million](https://www.sec.gov/Archives/edgar/data/1812360/000149315226016725/) |
| Research and development | [$182,498](https://www.sec.gov/Archives/edgar/data/1812360/000149315226016725/) | [$312,267](https://www.sec.gov/Archives/edgar/data/1812360/000149315226016725/) |
| Net income (loss) | [-$12.4 million](https://www.sec.gov/Archives/edgar/data/1812360/000149315226016725/) | [-$12.4 million](https://www.sec.gov/Archives/edgar/data/1812360/000149315226016725/) |
| Cash from operations | [-$3.9 million](https://www.sec.gov/Archives/edgar/data/1812360/000149315226016725/) | [-$2.8 million](https://www.sec.gov/Archives/edgar/data/1812360/000149315226016725/) |
| Cash and equivalents | [$207,453](https://www.sec.gov/Archives/edgar/data/1812360/000149315226038401/) | [$68,268](https://www.sec.gov/Archives/edgar/data/1812360/000149315226016725/) |

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $58,409.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about FOXO TECHNOLOGIES INC.

Did FOXO TECHNOLOGIES INC. do a reverse stock split?

Our latest story on this, dated Jul 6, 2026: "FOXO CEO gives mid-year 2026 update and says uplisting is under consideration". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/foxo-ceo-gives-mid-year-2026-update-says-uplisting-under-consideration/).

Has FOXO TECHNOLOGIES INC. sold convertible notes?

Our latest story on this, dated May 12, 2026: "FOXO exchanges Series A preferred for senior unsecured notes". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/foxo-exchanges-series-preferred-senior-unsecured-notes/).

Is FOXO TECHNOLOGIES INC. involved in a merger or acquisition?

Our latest story on this, dated Oct 29, 2026: "FOXO to buy Ludwig Enterprises preferred stock with majority voting power". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/foxo-buy-ludwig-enterprises-preferred-stock-majority-voting-power/).

Has FOXO TECHNOLOGIES INC. settled a lawsuit?

Our latest story on this, dated May 22, 2026: "FOXO settles J.H. Darbie fees and seeks a reverse stock split". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/foxo-settles-j-h-darbie-fees-seeks-reverse-stock-split/).

What is the ticker symbol of FOXO TECHNOLOGIES INC.?

FOXO TECHNOLOGIES INC. trades under the ticker FOXO on OTC.

Where is FOXO TECHNOLOGIES INC. listed?

FOXO TECHNOLOGIES INC. is listed on OTC.

Which country or territory is FOXO TECHNOLOGIES INC. listed under?

Our directory records FOXO TECHNOLOGIES INC. under United States.

Does aibio.space cover FOXO TECHNOLOGIES INC.?

aibio.space lists FOXO TECHNOLOGIES INC. among 2,820 public biotech companies and publishes its news here as stories appear.

What was FOXO TECHNOLOGIES INC.'s revenue last year?

$16.4 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is FOXO TECHNOLOGIES INC. profitable?

FOXO TECHNOLOGIES INC. reported a net loss of $12.4 million for the fiscal year ended Dec 31, 2025, and used $3.9 million of cash in operations, per its annual report to the SEC.

How much does FOXO TECHNOLOGIES INC. spend on research and development?

$182,498 in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does FOXO TECHNOLOGIES INC. have?

$58,409 in cash at Jun 30, 2026, per its 10-Q.

What is the latest FOXO TECHNOLOGIES INC. (FOXO) stock news?

Our latest story on FOXO TECHNOLOGIES INC., dated Oct 29, 2026: "FOXO to buy Ludwig Enterprises preferred stock with majority voting power". FOXO Technologies signed agreements to acquire preferred stock carrying majority voting power in Ludwig Enterprises, Inc. and to buy certain Ludwig notes. The transactions have not closed. [Source](https://aibio.space/news/foxo-buy-ludwig-enterprises-preferred-stock-majority-voting-power/).

What is FOXO TECHNOLOGIES INC.'s latest stock offering or financing news?

Our latest financing story, dated May 22, 2026: "FOXO settles J.H. Darbie fees and seeks a reverse stock split". FOXO settled amounts owed to J.H. Darbie & Co., Inc. with preferred stock and $175,000 in installments. Its majority holder approved a reverse split at a ratio of 1:1,000 to 1:10,000. [Source](https://aibio.space/news/foxo-settles-j-h-darbie-fees-seeks-reverse-stock-split/).

How long will FOXO TECHNOLOGIES INC.'s cash last?

From our story of May 28, 2026: The release does not give a current cash balance or a cash runway estimate. [Source](https://aibio.space/news/foxo-licenses-epigenetics-technology-longevityfp/).

## Investor discussion: FOXO TECHNOLOGIES INC.

Members talk about FOXO TECHNOLOGIES INC. (FOXO). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at FOXO TECHNOLOGIES INC., newest first. Each line links the filing it comes from.

1. 2026-08-14 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). [Source](https://www.sec.gov/Archives/edgar/data/1812360/000149315226038356/form8-k.htm)
2. 2026-08-14 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1812360/000149315226038401/form10-q.htm)
3. 2026-07-29 Mergers Reported a merger or acquisition agreement. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1812360/000149315226035110/ex99-1.htm)
4. 2026-07-06 Listings Reported a reverse stock split. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1812360/000149315226032156/ex99-1.htm)
5. 2026-07-01 Listings Reported a reverse stock split. SEC Form 8-K (Items 5.03,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1812360/000149315226031543/ex99-1.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:FOXO on TradingView](https://www.tradingview.com/symbols/OTC-FOXO/).

## Listing details

FOXO TECHNOLOGIES INC. is a public biotech or pharmaceutical company listed on OTC under the ticker FOXO, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: FOXO TECHNOLOGIES INC.

- **Ticker**: FOXO

- **Listing**: OTC

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/foxo-technologies/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "FOXO TECHNOLOGIES INC. (FOXO) news: reverse split", 2026-10-31, https://aibio.space/companies/foxo-technologies/